Investigators trialed injection of an immune-stimulating substance (poly-ICLC) into the prostate gland using MRI-ultrasound fusion technology in patients scheduled to undergo radical prostatectomy.

The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...

Swiss pharma giant Roche Holding AG's RHHBY 2025 results were affected by currency headwinds. Sales totaled $74.4 billion, ...

Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the year in 2025. Ozempic isn’t the only drug that mimics the natural GLP-1 ...

Roche is looking to a busy 2026 after 10 new molecules entered late-stage testing last year and as a potential launch of ...

Reinforces Synergistic Potential and Expands Opportunity Beyond Ovarian Cancer VANCOUVER, BC - January 29, 2026 (NEWMEDIAWIRE) - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB:BVAXF) ...

Health experts say it is unsafe, unregulated, and based on misinformation ...

Group results In 2025, Roche achieved sales growth of 7% (2% in CHF) to CHF 61.5 billion due to strong demand for pharmaceutical products and diagnostic solutions. The appreciation of the Swiss franc ...

The biopharmaceutical company released phase three clinical data for its type two diabetes treatment ecnoglutide in the peer-reviewed scientific journal.

This is 40-something. Kim Kardashian, 45, has tried to cling to her youth by undergoing skin-tightening treatments, traveling to Korea for stem cell therapy and even getting injected with salmon sperm ...

Medicare Part B covers many essential services, but not everything. Learn the 12 services it pays for and the 5 common costs ...

Humanity is sending people to the Moon again after half a century. The U.S. has resumed crewed lunar exploration, which was halted since Apollo 17 in 1972, through the Artemis program. As early as the ...